View the Full Schedule

Symposium I: Combination Treatments for Stimulant Use Disorders: A Promising New Direction

Presenters: Edward Nunes, MD, Chair, Professor of Psychiatry at Columbia University; Udi Ghitza, PhD, Co-Chair, Health Scientist Administrator, Program Officer at The National Institute on Drug Abuse; Frances Levin, MD, Kennedy-Leavy Professor of Psychiatry at Columbia University; Madhukar Trivedi, MD, Professor, University of Texas Southwestern Medical Center, Department of Psychiatry; Joy Schmitz, PhD, Professor, UT Southwestern; Steven Shoptaw, PhD, Moderator, Professor, UCLA School of Medicine

The lack of established medication treatments for stimulant use disorders is an important gap in the treatment options for such disorders. The studies presented here show evidence from large clinical trials supporting the effectiveness of combination medication strategies that may fill this gap.

Learning Objectives:

  • Understand the evidence bearing on naltrexone, bupropion and combined naltrexone + bupropion for treatment of methamphetamine use disorder.
  • Understand the evidence bearing on combined mixed amphetamine salts-extended, topiramate and their combination, as well as combinations of medications with contingency management for treatment of cocaine use disorder.
  • Understand rationales for combining treatments for cocaine use disorder and be able to apply them in clinical practice.

Symposium II: The Racial Origins and Impact of the War on Drugs: How Do We Heal?

Presenters: Bryon Adinoff, MD, Professor, Univ of Texas; Brenda Curtis, PhD, National Institute on Drug Abuse, National Institutes of Health; Rachel Knox, MBA, MD, Endocannabinologist and Cannabinoid Medicine Specialist; Howard Stevenson, PhD, Professor, University of Pennsylvania

This session will describe the role of race in the development of the drug laws in the US and increase the understanding and practicing of in-the-moment racial stress reduction strategies.

Learning Objectives:

  • Describe the role of race in the development of drug laws in the U.S.
  • Increase understanding and practicing of in-the-moment racial stress reduction strategies.
  • Describe the intersection of stigma, race, and SUDs and the role of language.

Symposium III: Cannabis and Cannabinoids – From Science to Practice to Policy: An International Perspective

Presenters: Gregory Bunt, MD, Chair, Assistant Professor, New York University; Bernard Le Foll, MD, PhD, MCFP, Professor, University of Toronto; Janna Cousijn, PhD, Associate Professor, Erasmus University Rotterdam; Kevin Sevarino, MD, PhD, Professor, Yale University School of Medicine

Learn the latest clinical studies and the public policy issues with cannabis and cannabinoids around the globe.

Learning Objectives:

  • Participants will be informed of the public policy issues related to cannabis and cannabinoids internationally.
  • Participants will be informed of the latest clinical studies with cannabinoids around the globe.
  • Participants will be informed of the relevance of global public policy and clinical studies related to cannabis and cannabinoids to addiction psychiatrists.